Saint John’s Named West Coast Center of Excellence for New Cardiac Technology
January 30, 2009
Santa Monica, Calif. and Portland, Ore. (December 2, 2008) – Saint John’s Health Center and Cheetah Medical, Inc. have announced that Saint John’s has been designated a Center of Excellence for the new state-of-the-art Reliant® Hemodynamic Monitoring System. The Reliant Monitor, in addition to other vital parameters, monitors how much blood the heart pumps with each heartbeat. Clinical studies have demonstrated that having this information available, and using it with other inputs to guide treatment, can help to prevent or decrease the incidence and risk of complications from a number of leading health conditions through improved patient management.
“Having these monitors will improve healthcare, especially for individuals determined to be at higher risk of heart and blood pressure complications, including after cardiac surgery, people with heart failure and those with serious infections, “ said John Robertson, MD, Director of Cardiac Surgery at Saint John's Health Center. “It’s really as simple and fast as placing four EKG electrodes on a person’s chest. We are pleased to be the first hospital on the West Coast to make this technology available to the community we serve.”
The noninvasive Reliant Monitor provides physicians and nurses with continuous cardiac output and other clinical information previously only available by inserting a catheter through the veins and into the patient’s heart. Such catheter insertions have been associated with additional costs and potential complications that can affect patient outcome and prolong the length of stay in the hospital, for which there is no additional reimbursement.
The Reliant Monitor uses BIOREACTANCE® technology, a proprietary method of advanced electronics and sophisticated computer processing to accurately calculate the flow of blood through the heart using only four skin surface electrodes. With this information, physicians can determine whether the amount of blood being pumped through the body is at optimal levels to maintain adequate blood pressure and deliver enough oxygen and nutrients to the body’s tissues, depending on the individual patient’s needs.
“With the rise in surgical procedures, including those performed on an aging U.S. population, as well as the growing incidence of heart failure and serious blood infections, Cheetah Medical is in the forefront of the latest breakthroughs in noninvasive heart monitoring to help clinicians provide optimal care of their patients in hospital operating and recovery rooms, intensive care units and in emergency departments,” stated Yoav Avidor, MD, CEO of Cheetah Medical. “We are honored to be a technology solutions provider for Saint John’s Health Center and are very pleased to recognize and work with this institution as our West Coast Center of Excellence.”
Saint John’s purchased seven Reliant Monitors units through gifts made to the Saint John’s Health Foundation through donors committed to keeping Saint John’s at the cutting edge of medical technology in serving the community.
# # #
Saint John’s Health Center
Since its founding in 1942 by the Sisters of Charity of Leavenworth, Saint John’s Health Center has been providing the patients and families of Santa Monica, West Los Angeles and ocean communities with compassionate, advanced medical care. Saint John’s provides a spectrum of treatment and diagnostic services with distinguished areas of excellence in cancer care, cardiac care, orthopedics, women’s health and specialized programs such as the internationally acclaimed John Wayne Cancer Institute. Saint John’s Health Center is dedicated to bringing to the community the most innovative advances in medicine and technology.
Cheetah Medical delivers accurate noninvasive cardiac output (CO), thoracic fluid content (TFC) and other vital hemodynamic monitoring parameters to provide continuous, clinically actionable data for fluid and drug optimization in acute care settings, including intensive care, emergency and perioperative patient management. The Reliant System uses Cheetah Medical’s proprietary BIOREACTANCE® technology which has validated performance accuracy and faster directional changes compared to invasive CO measurement methods, with less potential costs and risks. Cheetah Medical worldwide headquarters are located in Tel Aviv, Israel and its United States headquarters are located in Portland, Oregon. For more information, visit our website at www.cheetah-medical.com.
# # #